Stay updated on Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page
- Check6 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.6%
- Check13 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.6%
- Check20 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference2%
- Check27 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check49 days agoChange DetectedThe page has been updated to reflect the submission of results and has been revised to version 2.15.2.SummaryDifference0.2%
- Check64 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of the imvotamab study and its mechanisms, while adding new information about the study's collaborators and a revision number update.SummaryDifference22%
Stay in the know with updates to Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.